Yield10 Bioscience, Inc. (YTEN)
NASDAQ: YTEN · IEX Real-Time Price · USD
0.221
-0.018 (-7.62%)
Apr 26, 2024, 12:41 PM EDT - Market open
Company Description
Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States.
The company primarily focuses on commercializing products using the Camelina oilseeds. Its products include Camelina oil for use as a low-carbon feedstock oil for biofuels; Omega-3 oils for human nutrition; and PHA bioplastics.
The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017.
Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.
Yield10 Bioscience, Inc.
| Country | United States |
| Founded | 1992 |
| IPO Date | Nov 10, 2006 |
| Industry | Agricultural Inputs |
| Sector | Materials |
| Employees | 29 |
| CEO | Dr. Oliver P. Peoples Ph.D. |
Contact Details
Address: 19 Presidential Way, Suite 201 Woburn, Massachusetts 01801 United States | |
| Phone | 617-583-1700 |
| Website | yield10bio.com |
Stock Details
| Ticker Symbol | YTEN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001121702 |
| CUSIP Number | 98585K862 |
| ISIN Number | US98585K8624 |
| Employer ID | 04-3158289 |
| SIC Code | 0100 |
Key Executives
| Name | Position |
|---|---|
| Dr. Oliver P. Peoples Ph.D. | Co-Founder, President, Chief Executive Officer and Director |
| Dr. Anthony J. Sinskey Ph.D., Sc.D. | Co-Founder and Independent Director |
| Dr. Kristi D. Snell | Vice President of Research and Chief Science Officer |
| Lynne H. Brum | Vice President of Planning and Corporate Communications and Secretary |
| Charles B. Haaser | Vice President of Finance, Chief Accounting Officer and Treasurer |
| Dr. Nicholas Renegar Ph.D. | Director of Business Analytics and Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 25, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Apr 19, 2024 | PRE 14A | Other preliminary proxy statements |
| Apr 4, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 2, 2024 | PRE 14A | Other preliminary proxy statements |
| Apr 1, 2024 | 10-K | Annual Report |
| Apr 1, 2024 | 8-K | Current Report |
| Mar 29, 2024 | 8-K | Current Report |
| Mar 22, 2024 | 8-K/A | [Amend] Current report |
| Mar 22, 2024 | 8-K | Current Report |
| Feb 26, 2024 | 8-K | Current Report |